鋪灸聯(lián)合柳氮磺胺吡啶腸溶片治療腎虛督寒型強直性脊柱炎臨床療效觀察[權(quán)威資料]

《鋪灸聯(lián)合柳氮磺胺吡啶腸溶片治療腎虛督寒型強直性脊柱炎臨床療效觀察[權(quán)威資料]》由會員上傳分享，免費在線閱讀，更多相關(guān)內(nèi)容在教育資源-天天文庫。

1、鋪灸聯(lián)合柳氮磺胺吡啶腸溶片治療腎虛督寒型強直性脊柱炎臨床療效觀察　　[摘要]目的探討鋪灸聯(lián)合柳氮磺胺吡啶腸溶片治療腎虛督寒型強直性脊柱炎的臨床療效。方法將60例腎虛督寒型強直性脊柱炎患者隨機分為兩組，每組30例。對照組患者口服柳氮磺胺吡啶腸溶片，疼痛明顯者可以加服非甾體抗炎藥；治療組在對照組用藥基礎(chǔ)上聯(lián)合督脈鋪灸治療，總療程為6周，比較兩組的療效并觀察患者的BASDAI與BASFI評分、臨床指標(biāo)及實驗室指標(biāo)的變化。結(jié)果治療組總有效率為90.0%，明顯高于對照組的總有效率（70.0%），兩組比較，差異有統(tǒng)計學(xué)意義（P0.05）；治療后，兩組患者的

2、各項指標(biāo)較治療前顯著改善（P<0.05）；治療組在改善BASDAI與BASFI評分、指地距、枕墻距、Schober及ESR、CRP方面優(yōu)于對照組（P<0.05）；兩組在VAS評分、晨僵時間方面差異有統(tǒng)計學(xué)意義（P<0.01）。結(jié)論鋪灸聯(lián)合柳氮磺胺吡啶腸溶片治療腎虛督寒型強直性脊柱炎療效確切，可以顯著改善患者的臨床癥狀和體征，提高臨床治療效果，值得進一步推廣和應(yīng)用?！　關(guān)鍵詞]強直性脊柱炎；腎虛督寒型；鋪灸；柳氮磺胺吡啶腸溶片　　[]R246[]B[]1673-9701（2016）17-0116-04　　Therapeuticeffectofl

3、ongsnakemoxibudtioncombinedwithSASPinthetreatmentofkidneydeficiencyandDumeridiancoldenankylosingspondylitis　　RENXuanxuan1LIBangwei2　　1.DepartmentofChineseMedicine，ZhejiangHospital，Hangzhou310017，China；2.DepartmentofAcupuncture，ZhongshanHospitalofZhejiangProvince，Hangzhou3100

4、00，China　　[Abstract]ObjectiveToinvestigatetheclinicalefficacyoflongsnakemoxibudtioncombinedwithSASPinthetreatmentofankylosingspondylitiswhichbelongtokidneydeficiencyandDumeridiancoldeninTCM.MethodsAtotalof60ASpatientswererandomlydividedintotwogroups，with30casesineachgroup.Th

5、econtrolgrouppatientsreceivedSASP，andaddedNSAIDsifhadanobviouspain.Theobservationgroupreceivedthesamewayasthecontrolgroupandalsoreceivedlongsnakemoxibudtion.Twogroupsalltreatedfor6weeks，theclinicalefficacyandBASDAIscores，BASFIscores，clinicalandlaboratoryindicatorswerecompare

6、d.ResultsThetotaleffectiverateoftheobservationgroupwas90.0%，washigherthanthecontrolgroupinthetotalefficiency（70.0%），thedifferencewasstatisticallysignificant（P0.05）.Aftertreatment，eachindicatoroftwogroupsofpatientswassignificantlyimproved（P<0.05），andtheseindicatorsasBASDAIsco

7、res，BASFIscores，thedistanceformfingerstotheground，thedistanceformheadtowall，Schober，andESR，CRPofobservationgroupweresignificantlyimprovedthanthatinthecontrolgroup，thedifferencewassignificant（P<0.05）；ThedifferenceofVASanddurationformorningstiffnessintwogroupswerestatistically

8、significant（P　　[Keywords]Ankylosingspondylitis；KidneydeficiencyandDumeridia